4

RICHING MAY 2014 FORM 4

Company: Oncotelic Therapeutics, Inc.
Filed: May 30, 2014
Period of Report: May 30, 2014
Accession Number: 0001181431-14-021898

View Document ↗ View on SEC.gov ↗